Inhibitor Treatments: Now and the Future

preview_player
Показать описание

  1. National Bleeding Disorders Foundation
Рекомендации по теме
Inhibitor Treatments: Now 0:50:36

Inhibitor Treatments: Now and the Future

The Best BPH 0:00:23

The Best BPH Medications - Top 3 Treatments for Enlarged Prostate

Checkpoint Inhibitors | 0:01:04

Checkpoint Inhibitors | How do they works as a cancer treatment? | Cancer Research UK

What Are AML 0:04:26

What Are AML Inhibitor Therapies and How Do They Work?

Emerging AML Treatment 0:05:00

Emerging AML Treatment Options | Inhibitor Therapies

The future of 0:01:00

The future of CLL treatment: chemotherapy and targeted inhibitors

BRCA & PARP 0:11:49

BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI

Relapsed/Refractory Chronic Lymphocytic 0:28:47

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors

Emerging Therapeutic Innovations 0:27:54

Emerging Therapeutic Innovations for Vitiligo Treatment

Emerging AML Treatments: 0:03:22

Emerging AML Treatments: What Is Menin Inhibitor Therapy?

What Are the 0:02:22

What Are the Benefits of MPN Inhibitor Treatment?

Adverse events associated 0:01:53

Adverse events associated with BTK inhibitor therapy in NHL

Clinical updates on 0:02:07

Clinical updates on ALK inhibitor treatment strategies for NSCLC

How Does Inhibitor 0:02:43

How Does Inhibitor Therapy Work to Treat Myelofibrosis?

Where Are We 0:39:20

Where Are We Now in the Use of Interleukin-17 Inhibitors for Psoriatic Disease?

Molecularly-guided treatment of 0:02:10

Molecularly-guided treatment of advanced NSCLC: ALK inhibitor sequencing

New Oral Meds: 0:00:26

New Oral Meds: The Future of Treatment - TIK II Inhibitors

Is there any 0:00:29

Is there any role of FCR in CLL?

Maximizing the potential 0:35:35

Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer

Tailoring Bruton Tyrosine 0:37:49

Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

BTK Inhibitors for 0:49:28

BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients

When to use 0:05:07

When to use a JAK inhibitor in RA: Dr. Janet Pope

BTK Inhibitor Treatment 0:03:27

BTK Inhibitor Treatment Side Effects | What CLL Patients Should Know

Looking beyond JAK 0:03:21

Looking beyond JAK inhibitors: novel targeted therapies and strategies for MPN treatment

join shbcf.ru